0
     

Report Added
Report already added
Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027

Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027

The global microcatheter market is projected to reach USD 1,082 million by 2027 from USD 828 million in 2022, at a CAGR of 5.5% during the forecast period. Factors such as the growing adoption of minimally invasive procedures, rising geriatric individuals, Increasing prevalence of cardiovascular and neurovascular diseases, and increasing sedentary lifestyles and eating habits are increasing cardiac arrest cases, thereby increasing the minimally invasive procedures in hospitals.

“The delivery microcatheter to hold the largest share of the market in 2022”

The delivery microcatheter holds the largest market share in 2022. The large share of this segment can be attributed to knowing the use of the microcatheter properly and the increasing number of nonsurgical procedures replacing open surgeries.

“The clinics, hospitals, and medical spas segment is projected to register the highest CAGR during the forecast period”

Based on end users, the microcatheter market is segmented into hospitals, Surgical centers, and Specialty clinics. The hospitals, Surgical centers, and Specialty clinics are projected to register the highest CAGR during the forecast period of 2022 to 2027. The key factors supporting segment growth are the availability of high-quality non-surgical equipment and personnel in hospitals, growing awareness about minimally invasive procedures performed in hospital settings, and the increasing number of plastic surgeons.

“The market in North America region is expected to witness the highest growth during the forecast period.”

North America accounted for the largest market share—46.4%—in 2022. This share can be attributed to a large number of target procedures (including cardiovascular, neurovascular, and oncology, among others) performed in the region coupled with the high prevalence of related diseases & disorders. In addition, the presence of a well-established healthcare system in the US and ongoing investments by hospitals to upgrade & expand operating capabilities are some of the other factors expected to fuel the growth of the microcatheters market in North America.

While growth in the US and European markets for microcatheters is reaching stagnancy due to market saturation, the market in the APAC is expected to witness significant growth in the coming years. The microcatheters market in the APAC region is expected to register a CAGR of 6.9% during the forecast period, primarily due to the growing number of hospitals in Asian countries, favorable government initiatives, growing healthcare industry, and increasing prevalence of target diseases & disorders in the region.

A breakdown of the primary participants referred to for this report is provided below:
•By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
•By Designation: C-level–10%, Director-level–76%, and Others–14%
•By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%

The prominent players in the microcatheter market Boston Scientific Corporation. (US), Stryker Corporation (US), Teleflex Incorporated (US), Cook Group (US), Becton Dickinson and Company (US), Asahi Intecc Co.ltd (Japan) among others.

Research Coverage
This report studies the microcatheter market based on product,product design, end user and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report
The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:
•Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microcatheter market.
•Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the microcatheter market..
•Market Development: Comprehensive information on lucrative emerging regions
•Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the microcatheter market.
•Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
Table of Contents

1INTRODUCTION24
1.1STUDY OBJECTIVES24
1.2MARKET DEFINITION24
1.2.1INCLUSIONS AND EXCLUSIONS24
1.3MARKET SCOPE25
1.3.1MARKETS COVERED25
FIGURE 1MICROCATHETERS MARKET, BY SEGMENTATION25
FIGURE 2MICROCATHETERS MARKET, BY REGION25
1.3.2YEARS CONSIDERED26
1.4CURRENCY CONSIDERED26
1.5STAKEHOLDERS26
1.6SUMMARY OF CHANGES27
2RESEARCH METHODOLOGY28
2.1RESEARCH DATA28
2.2RESEARCH DESIGN28
FIGURE 3MICROCATHETERS MARKET: RESEARCH DESIGN28
2.2.1SECONDARY DATA29
2.2.2PRIMARY DATA29
FIGURE 4PRIMARY SOURCES29
2.2.2.1Key data from primary sources30
2.2.2.2Insights from primary experts30
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS31
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION31
2.3MARKET SIZE ESTIMATION31
FIGURE 7SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS32
FIGURE 8TOP-DOWN APPROACH33
2.4MARKET BREAKDOWN AND DATA TRIANGULATION35
FIGURE 9DATA TRIANGULATION METHODOLOGY35
2.5MARKET SHARE ESTIMATION35
2.6RESEARCH ASSUMPTIONS36
2.7STUDY LIMITATIONS36
2.7.1METHODOLOGY-RELATED LIMITATIONS36
2.8RISK ASSESSMENT36
TABLE 1LIMITATIONS AND ASSOCIATED RISKS36
3EXECUTIVE SUMMARY37
FIGURE 10MICROCATHETERS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)37
FIGURE 11MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2022 VS. 2027 (USD MILLION)38
FIGURE 12MICROCATHETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)38
FIGURE 13MICROCATHETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)39
FIGURE 14ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD39
4PREMIUM INSIGHTS41
4.1MICROCATHETERS MARKET OVERVIEW41
FIGURE 15TECHNOLOGICAL ADVANCEMENTS AND RISING CHRONIC DISEASE INCIDENCE TO DRIVE DEMAND41
4.2MICROCATHETERS MARKET SHARE, BY COUNTRY AND PRODUCT42
FIGURE 16NORTH AMERICA TO HOLD LARGEST SHARE OF GLOBAL MARKET42
4.3MICROCATHETERS MARKET SHARE, BY END USER42
FIGURE 17HOSPITALS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD42
4.4GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET43
FIGURE 18INDIA TO GROW AT HIGHEST RATE DURING 2022–202743
5MARKET OVERVIEW44
5.1INTRODUCTION44
5.2MARKET DYNAMICS44
FIGURE 19MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES44
5.2.1DRIVERS45
5.2.1.1Technological advancements in interventional cardiology45
5.2.1.2Expansion of patient population suffering from chronic illness45
5.2.1.3Increasing conferences and symposia to spread awareness about benefits of microcatheters45
5.2.2RESTRAINTS46
5.2.2.1Stringent regulatory guidelines and high cost of drug approval46
5.2.2.2Lack of awareness about microcatheters in underdeveloped or emerging countries46
5.2.3OPPORTUNITIES46
5.2.3.1Rising number of patients suffering from chronic diseases and cancer globally46
5.3KEY STAKEHOLDERS AND BUYING CRITERIA47
5.3.1KEY STAKEHOLDERS IN BUYING PROCESS47
FIGURE 20INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET47
TABLE 2INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR MICROCATHETERS MARKET47
5.4PORTER’S FIVE FORCES ANALYSIS47
5.4.1OVERVIEW47
TABLE 3MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS48
5.4.2THREAT OF NEW ENTRANTS48
5.4.3THREAT OF SUBSTITUTES48
5.4.4BARGAINING POWER OF SUPPLIERS48
5.4.5BARGAINING POWER OF BUYERS48
5.4.6DEGREE OF COMPETITION49
5.5REGULATORY ANALYSIS49
5.5.1US49
TABLE 4US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS50
5.5.2EUROPE50
5.5.3JAPAN50
TABLE 5JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA51
5.6REIMBURSEMENT ANALYSIS51
TABLE 6CPT CODES FOR MAJOR MICROCATHETERS51
5.7ECOSYSTEM ANALYSIS52
5.8VALUE CHAIN ANALYSIS53
5.8.1RESEARCH AND DEVELOPMENT53
5.8.2PROCUREMENT AND PRODUCT DEVELOPMENT53
5.8.3MARKETING, SALES & DISTRIBUTION, AND POST-SALES SERVICES53
FIGURE 21VALUE CHAIN ANALYSIS53
5.9SUPPLY CHAIN ANALYSIS54
5.9.1PROMINENT COMPANIES54
5.9.2SMALL & MEDIUM-SIZED COMPANIES54
5.9.3END USERS54
FIGURE 22SUPPLY CHAIN ANALYSIS54
5.10PATENT ANALYSIS54
5.11TRADE ANALYSIS55
TABLE 7IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION)55
TABLE 8EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2020–2022 (USD MILLION)55
5.12KEY CONFERENCES AND EVENTS IN 2022–202356
TABLE 9MICROCATHETERS MARKET: DETAILED LIST OF MAJOR CONFERENCES AND EVENTS56
5.13TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES56
FIGURE 23EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX57
6MICROCATHETER MARKET, BY PRODUCT58
6.1INTRODUCTION59
TABLE 10MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)59
TABLE 11MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)59
TABLE 12MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)60
TABLE 13MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)60
6.2DELIVERY MICROCATHETERS60
6.2.1INCREASED NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET60
TABLE 14DELIVERY MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)61
TABLE 15DELIVERY MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)61
TABLE 16DELIVERY MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)62
TABLE 17DELIVERY MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)62
6.3ASPIRATION MICROCATHETERS63
6.3.1INCREASING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL PROCEDURES TO AUGMENT MARKET63
TABLE 18ASPIRATION MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)63
TABLE 19ASPIRATION MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)63
TABLE 20ASPIRATION MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)64
TABLE 21ASPIRATION MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)64
6.4DIAGNOSTICS MICROCATHETERS65
6.4.1LARGE PATIENT POPULATION FOR VASCULAR DISEASES TO AID MARKET65
TABLE 22DIAGNOSTIC MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)65
TABLE 23DIAGNOSTIC MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)65
TABLE 24DIAGNOSTIC MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)66
TABLE 25DIAGNOSTIC MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)66
6.5STEERABLE MICROCATHETERS67
6.5.1GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO BOOST MARKET67
TABLE 26STEERABLE MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)67
TABLE 27STEERABLE MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)67
TABLE 28STEERABLE MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)68
TABLE 29STEERABLE MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)68

7MICROCATHETERS MARKET, BY PRODUCT DESIGN69
7.1INTRODUCTION70
TABLE 30MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)70
7.2SINGLE LUMEN MICROCATHETERS70
7.2.1INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO PROPEL MARKET70
TABLE 31SINGLE LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)71
7.3DUAL-LUMEN MICROCATHETERS71
7.3.1PRODUCT ADVANTAGES AND INCREASED ADOPTION OF CATHETERS TO DRIVE MARKET71
TABLE 32DUAL-LUMEN MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)72
8MICROCATHETERS MARKET, BY APPLICATION73
8.1INTRODUCTION74
TABLE 33MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)74
8.2CARDIOVASCULAR APPLICATIONS74
8.2.1PROCEDURAL BENEFITS DURING CRITICAL CARDIAC SURGERIES TO AID MARKET74
TABLE 34MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)75
8.3NEUROVASCULAR APPLICATIONS75
8.3.1INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET75
TABLE 35MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)76
8.4PERIPHERAL VASCULAR APPLICATION76
8.4.1RISING TARGET DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO STIMULATE MARKET76
TABLE 36MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)77
8.5ONCOLOGY APPLICATIONS77
8.5.1INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET77
TABLE 37MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)78
9MICROCATHETERS MARKET, BY END USER79
9.1INTRODUCTION80
TABLE 38MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)80
9.2HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS80
9.2.1LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO PROPEL MARKET80
TABLE 39MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION)81
9.3AMBULATORY CARE CENTERS81
9.3.1LIMITED SURGICAL CAPABILITIES OF AVAILABLE PRODUCTS TO RESTRAIN ADOPTION81
TABLE 40MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2027 (USD MILLION)82
10MICROCATHETERS MARKET, BY REGION83
10.1INTRODUCTION84
TABLE 41MICROCATHETERS MARKET, BY REGION, 2020–2027 (USD MILLION)84
10.2NORTH AMERICA85
FIGURE 24NORTH AMERICA: MARKET SNAPSHOT85
TABLE 42NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)85
TABLE 43NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)86
TABLE 44NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)86
TABLE 45NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)87
TABLE 46NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)87
10.2.1US88
10.2.1.1US to dominate North American market during forecast period88
TABLE 47US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)88
10.2.2CANADA88
10.2.2.1Increasing prevalence of target diseases and high demand for timely diagnosis to propel market88
TABLE 48CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)89
10.3EUROPE89
TABLE 49EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)89
TABLE 50EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)90
TABLE 51EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)90
TABLE 52EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)90
TABLE 53EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)91
10.3.1GERMANY91
10.3.1.1Increasing aging population and rising life expectancy to boost market91
TABLE 54GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)91
10.3.2FRANCE92
10.3.2.1Significant evolution of healthcare sector to drive market92
TABLE 55FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)92
10.3.3UK92
10.3.3.1High burden of chronic diseases and large volume of surgeries to augment market92
TABLE 56UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)93
10.3.4ITALY93
10.3.4.1Increasing geriatric population to aid growth93
TABLE 57ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)93
10.3.5SPAIN93
10.3.5.1Increasing technological developments in healthcare sector to propel market93
TABLE 58SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)94
10.3.6REST OF EUROPE94
TABLE 59REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)94
10.4ASIA PACIFIC95
FIGURE 25ASIA PACIFIC: MARKET SNAPSHOT95
TABLE 60ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)96
TABLE 61ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)96
TABLE 62ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)96
TABLE 63ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)97
TABLE 64ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)97
10.4.1JAPAN98
10.4.1.1Increasing geriatric population and surgical procedures to drive market98
TABLE 65JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)98
10.4.2CHINA99
10.4.2.1Growing prevalence of chronic disorders and developing healthcare infrastructure to aid growth99
TABLE 66CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)99
10.4.3INDIA100
10.4.3.1Increasing target patient population with rising availability of advanced surgical treatments to drive market100
TABLE 67INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)100
10.4.4AUSTRALIA100
10.4.4.1Developing healthcare sector and increasing availability of advanced surgical treatments to stimulate market100
TABLE 68AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)101
10.4.5SOUTH KOREA101
10.4.5.1Growing target patient population for cardiovascular diseases to drive market101
TABLE 69SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)101
10.4.6REST OF ASIA PACIFIC102
TABLE 70REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)102
10.5LATIN AMERICA102
10.5.1FAVORABLE ECOSYSTEM FOR MEDICAL EQUIPMENT AND SUPPLIES TO DRIVE MARKET102
TABLE 71LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)103
TABLE 72LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)103
TABLE 73LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)103
TABLE 74LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)104
TABLE 75LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)104
10.6MIDDLE EAST & AFRICA105
10.6.1INCREASING FOCUS OF MARKET PLAYERS TO ESTABLISH THEIR PRESENCE TO PROPEL MARKET105
TABLE 76MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)105
TABLE 77MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2027 (USD MILLION)106
TABLE 78MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)106
TABLE 79MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2027 (USD MILLION)106
11COMPETITIVE LANDSCAPE107
11.1OVERVIEW107
11.2KEY PLAYER STRATEGIES/RIGHT TO WIN107
FIGURE 26OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MICROCATHETERS MARKET108
11.3MARKET RANKING ANALYSIS109
FIGURE 27MICROCATHETERS MARKET (2021)109
11.3.1BOSTON SCIENTIFIC CORPORATION109
11.3.2ASAHI INTECC CO., LTD.110
11.3.3MEDTRONIC PLC110
11.3.4TELEFLEX110
11.3.5TERUMO MEDICAL CORPORATION111
11.4REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS111
FIGURE 28REVENUE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET111
11.5COMPETITIVE BENCHMARKING OF TOP 26 PLAYERS112
TABLE 80OVERALL FOOTPRINT OF COMPANIES112
TABLE 81PRODUCT FOOTPRINT OF COMPANIES (26 COMPANIES)113
TABLE 82END USER FOOTPRINT OF COMPANIES (26 COMPANIES)114
TABLE 83REGIONAL FOOTPRINT OF COMPANIES (26 COMPANIES)115
11.6COMPANY EVALUATION QUADRANT116
11.6.1STARS117
11.6.2EMERGING LEADERS117
11.6.3PERVASIVE PLAYERS117
11.6.4PARTICIPANTS117
FIGURE 29MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)118
11.7START-UPS/SMES EVALUATION QUADRANT118
11.7.1PROGRESSIVE COMPANIES118
11.7.2DYNAMIC COMPANIES118
11.7.3STARTING BLOCKS119
11.7.4RESPONSIVE COMPANIES119
FIGURE 30MICROCATHETERS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2021)119
11.8COMPETITIVE SCENARIO120
11.8.1PRODUCT LAUNCHES AND APPROVALS120
TABLE 84PRODUCT LAUNCHES AND APPROVALS, 2019–2022120
11.8.2ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS121
TABLE 85ALLIANCES, PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2019–2022121
12COMPANY PROFILES122
(Business Overview, Products/Services/Solutions offered, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats)*
12.1KEY PLAYERS122
12.1.1BOSTON SCIENTIFIC CORPORATION122
TABLE 86BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW122
FIGURE 31BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2021)123
12.1.2ASAHI INTECC CO., LTD.125
TABLE 87ASAHI INTECC CO., LTD: COMPANY OVERVIEW125
FIGURE 32ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2021)125
12.1.3MEDTRONIC PLC127
TABLE 88MEDTRONIC PLC: COMPANY OVERVIEW127
FIGURE 33MEDTRONIC PLC.: COMPANY SNAPSHOT (2021)128
12.1.4STRYKER130
TABLE 89STRYKER: COMPANY OVERVIEW130
FIGURE 34STRYKER: COMPANY SNAPSHOT (2021)131
12.1.5BECTON, DICKINSON AND COMPANY133
TABLE 90BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW133
FIGURE 35BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)134
12.1.6TERUMO MEDICAL CORPORATION136
TABLE 91TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW136
FIGURE 36TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2021)137
12.1.7MERIT MEDICAL SYSTEMS, INC.139
TABLE 92MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW139
FIGURE 37MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2021)140
12.1.8CARDINAL HEALTH142
TABLE 93CARDINAL HEALTH: COMPANY OVERVIEW142
FIGURE 38CARDINAL HEALTH: COMPANY SNAPSHOT (2021)143
12.1.9B. BRAUN MELSUNGEN AG145
TABLE 94B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW145
12.1.10COOK MEDICAL GROUP147
TABLE 95COOK MEDICAL GROUP: COMPANY OVERVIEW147
12.1.11TELEFLEX150
TABLE 96TELEFLEX: COMPANY OVERVIEW150
12.1.12JOHNSON & JOHNSON151
TABLE 97JOHNSON & JOHNSON: COMPANY OVERVIEW151
12.1.13ANGIODYNAMICS152
TABLE 98ANGIODYNAMICS: COMPANY OVERVIEW152
12.1.14PENUMBRA153
TABLE 99PENUMBRA: COMPANY OVERVIEW153
12.1.15BTG PLC154
TABLE 100BTG PLC: COMPANY OVERVIEW154
12.1.16GUERBET LLC155
TABLE 101GUERBET LLC: COMPANY OVERVIEW155
12.1.17EMBOLX INC.156
TABLE 102EMBOLX INC.: COMPANY OVERVIEW156
12.1.18TOKAI MEDICAL157
TABLE 103TOKAI MEDICAL: COMPANY OVERVIEW157
12.1.19KANEKA CORPORATION158
TABLE 104KANEKA CORPORATION.: COMPANY SNAPSHOT158
12.1.20INTEGER HOLDINGS CORPORATION159
TABLE 105INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW159
12.1.21LIBATAPE PHARMACEUTICAL CO., LTD.159
TABLE 106LIBATAPE PHARMACEUTICAL CO., LTD.: COMPANY OVERVIEW159
12.1.22MICROVENTION TERUMO160
TABLE 107MICROVENTION TERUMO: COMPANY OVERVIEW160
12.1.23REFLOW MEDICAL160
TABLE 108REFLOW MEDICAL: COMPANY OVERVIEW160
12.1.24SPARTAN MICRO161
TABLE 109SPARTAN MICRO: COMPANY OVERVIEW161
12.1.25TRANSIT SCIENTIFIC161
TABLE 110TRANSIT SCIENTIFIC: COMPANY OVERVIEW161
12.1.26TRISALUS LIFE SCIENCES, INC.162
TABLE 111TRISALUS LIFE SCIENCES, INC.: COMPANY OVERVIEW162
*Details on Business Overview, Products Offered, Recent Developments, Deals, MnM view, Key strengths/right to win, Strategic choices made, Weakness/competitive threats might not be captured in case of unlisted companies.
13APPENDIX163
13.1DISCUSSION GUIDE163
13.2KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL166
13.3CUSTOMIZATION OPTIONS168
13.4RELATED REPORTS168
13.5AUTHOR DETAILS169

Report Title: Microcatheter Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospital and Ambulatory Surgical Centers) - Global Forecasts to 2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW